Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 24.40
-0.30 (-1.21%)
Jun 11, 2026, 5:35 PM CET
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.79 billion as of June 11, 2026. Its market cap has increased by 12.45% in one year.
Market Cap
1.79B
Enterprise Value
2.08B
Revenue
952.17M
Ranking
n/a
PE Ratio
19.68
Stock Price
€24.40
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.79B, an increase of 473.30%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 1.81B | 16.13% |
| Dec 31, 2025 | 1.56B | 27.67% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 49.68B |
| argenx SE | 47.46B |
| Financière de Tubize | 10.23B |
| Ion Beam Applications | 481.80M |
| Onward Medical | 191.55M |
| Hyloris Pharmaceuticals | 140.00M |
| Nyxoah | 107.19M |
| Sequana Medical NV | 43.56M |